Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
August 15, 2017 06:35 pm ETEstimated Read Time: 4 Minutes
Medical cannabis will soon be available for New York medical marijuana patients in the form of chewable tablets, lozenges, and ointments under new regulations announced Thursday by the state New York Health Department.
As part of an effort to expand New York’s low turnover of a medical weed program, the Health Department announced that it would authorize several new ways New York medical marijuana patients can administer the drug and also make it easier for prospective patients to gain access to licensed dispensaries. New products to be allowed will also include marijuana patches, effervescent tablets, and numerous non-smokable forms of ground plant material.
Prospective patients who are interested in New York’s medical marijuana program see this as good news, because now they can utilize the services of Veriheal, who helps non- patients become New York Medical Marijuana patients.
Previously, New York’s medical marijuana offerings were mostly limited to liquids and oils for vaporization and capsules to be taken only orally. Only non-smokable forms of the drug are allowed under state law in NY.
One of the main directives for improving New York state’s medicinal cannabis program is to broaden the types of products they can offer—mainly anything that is not in smokeable form. In regards to this particular ordinance, commodities such as topicals, lotions, tablets, lozenges, patches, oils, and more, would be more easily obtainable. These products could be both manufactured and distributed within the state just as long as they are held to strict testing standards
The NY health commissioner stated “This is yet another positive step forward for New York State’s Medical Marijuana Program… These regulations will continue to improve the program in several ways, including making new forms of medical marijuana available and improving the dispensing facility experience.”
As part of the new regulations introduced this month, the state intends to ease restrictions that prevented anyone other than state-certified marijuana patients from entering NY medical dispensaries. Under the new rules, which are likely to take effect in September, any prospective patient can enter a facility to gain information and learn about the program in person.
See If You Qualify For Medical Marijuana -Select Your State!
Zucker has also announced that the state intended to offer a shorter, two-hour online training program for doctors to go along with the four-hour program now available. Under state law, only doctors who have taken the training program can certify patients for NY medical cannabis use.
Since it started in January of 2016, New York’s medical marijuana program has struggled to attract both prospective patients and future doctors as well. As of Tuesday, there were only 26,000 New York Medical Marijuana patients and 1,155 registered practitioners participating in the program.
“We welcome these regulatory changes and are hopeful they will help enhance patient access,” Ari Hoffnung, CEO of Vireo Health of New York, one of the first companies licensed to grow pot in the state.
The new regulations were the latest of several attempts that the state has taken to try and boost the program enrollment. Last week, the state announced that it was licensing five new companies to grow and distribute the drug, effectively doubling the number of medical marijuana producers operating in New York.
Earlier this year, the state added chronic pain to the list of ailments eligible for marijuana treatment approval. A bill to add post-traumatic stress disorder (PTSD) to the list was passed by the Legislature this year but has not yet been sent to Gov. Cuomo, who hasn’t said whether he’d sign it into law or not. Following in the footsteps of states like Minnesota, New York legislators ruled that post-traumatic stress disorder (PTSD) is a valid qualifying condition for medicinal marijuana treatment.
When do all these changes take place? Well fortunately for both patients and dispensaries, there won’t be a long waiting period for the changes to come into effect. In New York, once addendums are submitted there is a 30-day wait period for public comment, and if not blocked they become permanent.
Anthony is the Marketing Director of Veriheal with a keen sense for sustainable branding techniques and creative marketing solutions meant for the cannabis space. He is inspired by art and human culture and occasionally gives us a sneak peek into what is happening behind the scenes at Veriheal.
With more people turning to cannabis for medical relief, many wonder if it’s safe to combine weed with prescription medications like prednisone. Prednisone is a potent corticosteroid that helps combat inflammation and regulate the immune system. Cannabis also has well-documented anti-inflammatory properties, making the idea of combining the two appealing for people managing chronic pain,…
Sipping on a chilled glass of wine can be a relaxing and luxurious way to unwind. Smoking a joint, on the other hand, is the fastest way to experience relaxation, pain relief, and other benefits from cannabinoids. But what if you could combine both? Enter cannabis wine, the beverage that melds the social ease of…
Anecdotal and scientific evidence highlighting cannabis medical and therapeutic benefits is plentiful, boosting the plant’s reputation as a wonder herb. Some even consider the marijuana plant the closest we may ever get to a fountain of youth. But is that true? Can cannabis really help you live longer or reverse the effects of aging? Willie…
Born between 1997 and 2012, Gen Z is the largest generation in history. The cohort currently makes up 25% of the global population, and although only a small portion of them have reached legal age, their size and spending power have already begun to have massive impacts on our culture at large. The cannabis industry,…
As perhaps one of the most talked-about topics for U.S. consumers and businesses, inflation dominates current news headlines because of how much it affects every one of our wallets. Since COVID-19 rocked the economy, cannabis businesses and supply chains claim to have been playing catch-up to get back to business as usual. However, the question…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.